SCHEMBL90420

SCHEMBL90420

CCOCCCC(C)C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26932455 0.95 ALDH1A1 (0.36)
SCHEMBL26932443 0.95 ALDH1A1 (0.36)
SCHEMBL26932451 0.95 ALDH1A1 (0.36)
SCHEMBL26932446 0.95 ALDH1A1 (0.36)
SCHEMBL9633841 0.92 LMNA (0.43)
SCHEMBL23355933 0.90 LMNA (0.42)
SCHEMBL12231695 0.90 LMNA (0.42)
SCHEMBL25437774 0.90 LMNA (0.42)
SCHEMBL23501570 0.90 LMNA (0.42)
SCHEMBL4448715 0.90 LMNA (0.42)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 116 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5753671-A Imidazopyridine derivatives as dual histamine (H1) and platelet activating factor (PAF) antagonists BRITISH BIOTECH PHARMACEUTICALS LIMITED (GB) 1998-05-19 US claimed
EP-0775139-A1 IMIDAZOPYRIDINE DERIVATIVES AS DUAL HISTAMINE (H1) AND PLATELET ACTIVATING FACTOR (PAF) ANTAGONISTS BRITISH BIOTECH PHARMACEUTICALS LIMITED (GB) 1997-05-28 EP claimed
WO-1996005201-A1 IMIDAZOPYRIDINE DERIVATIVES AS DUAL HISTAMINE (H1) AND PLATELET ACTIVATING FACTOR (PAF) ANTAGONISTS BRITISH BIOTECH PHARMACEUTICALS LIMITED (GB) 1996-02-22 WO claimed
US-11822244-B2 Compound, resin, resist composition and method for producing resist pattern SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2023-11-21 US disclosed
US-20230365568-A1 PLK1 POLO BOX DOMAIN INHIBITORS AND METHOD OF TREATING CANCER THE UNITED STATES OF AMERICA,AS REPRESENTED BY THE SECRETARY,DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) 2023-11-16 US disclosed
US-20230314941-A1 CARBOXYLATE, CARBOXYLIC ACID GENERATOR, RESIN, RESIST COMPOSITION AND METHOD FOR PRODUCING RESIST PATTERN SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2023-10-05 US disclosed
US-20230305391-A1 SALT, ACID GENERATOR, RESIN, RESIST COMPOSITION AND METHOD FOR PRODUCING RESIST PATTERN SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2023-09-28 US disclosed
US-11739056-B2 Carboxylate, carboxylic acid generator, resist composition and method for producing resist pattern SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2023-08-29 US disclosed
US-11681224-B2 Resin, resist composition and method for producing resist pattern SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2023-06-20 US disclosed
US-20230161256-A1 SALT, ACID GENERATOR, RESIN, RESIST COMPOSITION AND METHOD FOR PRODUCING RESIST PATTERN SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2023-05-25 US disclosed
US-20230161243-A1 SALT, ACID GENERATOR, RESIN, RESIST COMPOSITION AND METHOD FOR PRODUCING RESIST PATTERN SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2023-05-25 US disclosed
EP-0328955-B1 Process for the preparation of imidazole-2-carboxylic acids BASF AG (DE) 1995-05-03 EP disclosed
US-5266171-A Electrochemical oxidation in and etherification BASF AKTIENGESELLSCHAFT (DE) 1993-11-30 US disclosed
US-5179210-A PREPARATION OF N-SUBSTITUTED IMIDAZOLES BASF AKTIENGESELLSCHAFT (DE) 1993-01-12 US disclosed
US-5117004-A Carboxylation with carbon dioxide BASF AKTIENGESELLSCHAFT (DE) 1992-05-26 US disclosed
EP-0460451-A1 Process for the preparation of alpha-hydroxymethyl-ketals BASF Aktiengesellschaft (DE) 1991-12-11 EP disclosed
EP-0457139-A2 Process for the preparation of N-substituted imidazoles BASF Aktiengesellschaft (DE) 1991-11-21 EP disclosed
EP-0328955-A2 Process for the preparation of imidazole-2-carboxylic acids BASF Aktiengesellschaft (DE) 1989-08-23 EP disclosed
EP-0004335-A2 Prostacyclin analogs, process and intermediates for their preparation and their use as medicines HOECHST AKTIENGESELLSCHAFT (DE) 1979-10-03 EP disclosed
EP-0001270-A1 Analogues of prostacycline, methods for their preparation and their use in the treatment of circulatory diseases HOECHST AKTIENGESELLSCHAFT (DE) 1979-04-04 EP disclosed